Burnham Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Burnham Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,770	Closed	-$205K	–	218
2016 Q1	$205K	Buy	+3,770	New	+$221K	0.07%	198
2013 Q4	–	Sell	-6,670	Closed	-$252K	–	265
2013 Q3	$252K	Buy	6,670 +150	+2%	+$5.85K	0.06%	220
2013 Q2	$256K	Buy	+6,520	New	+$254K	0.07%	215

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Burnham Asset Management's TEVA Position: Q2 2016 in Review

Burnham Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2016, closing a stake of 3,770 shares — an estimated $205K sold.

Burnham Asset Management first reported a position in TEVA in Q2 2013 and held it in 3 quarters. The position peaked at $256K in Q2 2013. 812 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

Burnham Asset Management reported no remaining Teva Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Burnham Asset Management sold 3,770 Teva Pharmaceuticals shares in Q2 2016, an estimated $205K.
Burnham Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 3 quarters.
Burnham Asset Management's Teva Pharmaceuticals position peaked at $256K in Q2 2013.
812 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2016.

Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.